Search Results

MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it has appointed Doug Rice as the Company’s Chief Financial Officer, effective today.

Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.

Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.

Mercury Bio, (www.mercurybio.com) a Santa Fe, NM-based biotech company commercializing an innovative and highly disruptive drug delivery platform

Kytopen, a leading biotechnology company specializing in scalable gene editing platforms, today announces a strategic collaboration with Rice University’s prestigious Omid Veiseh Laboratory.

Monopar’s pipeline includes clinical-stage radiopharmaceuticals targeting advanced solid tumors and late-stage ALXN1840, a treatment for Wilson Disease

Valent BioSciences LLC and Kansas State University, Manhattan, Kansas, announce a formal long-term agreement to advance critical research in the areas of soil health and carbon smart farming. Kansas State University Distinguished Professor of Soil Microbiology, Dr. Charles W. Rice, a world-renowned researcher in carbon cycling and climate change, will oversee this initiative.

Cynosure, LLC, a leader in medical aesthetics systems and technologies, announced today a new investment of $60 million from lead investor Clayton, Dubilier & Rice.